openPR Logo
Press release

Pulmonary And Respiratory Drug Delivery Market Comprehensive Study On AptarGroup S. A.,Novartis, Roche,TTP plc,Hovione,Teva Pharmaceutical, OMRON Group, Catalent Pharma Solutions., Sunovion Pharmaceuticals., Cipla, GlaxoSmithKline Pharma GmbH,3M

01-25-2019 04:18 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Global Pulmonary/Respiratory Drug Delivery Market

Global Pulmonary/Respiratory Drug Delivery Market

Global Pulmonary And Respiratory Drug Delivery market 2018-2025 report offers a extensive and precise estimates and forecasts study of Pulmonary And Respiratory Drug Delivery industry along with the analysis of essential features providing key industry insights to the readers. The Pulmonary And Respiratory Drug Delivery market research report further delivers an methodical outlook of the industry by studying key components impacting the industry such as Pulmonary And Respiratory Drug Delivery market growth, consumption volume, emerging trends and industry cost structures during the forecast period.

Global Pulmonary/Respiratory Drug Delivery Market, By Canister Type (Plain Canisters, Coated Canister), Application (Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis), End User (Hospitals & Clinics, Home Care Settings), Formulation, Geography (North America, South America, Europe, Asia-Pacific, Middle East And Africa)– Industry Trends and Forecast to 2025

Get Free Sample of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-pulmonary-respiratory-drug-delivery-market

Market Analysis:

Global pulmonary and respiratory drug delivery market is expected to reach USD 63.79 billion by 2025, from USD 38.63 billion in 2017 growing at a CAGR of 6.7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Key Developments in the Market:

• In March 2016, FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome.

• In April 2013, Bayer Healthcare launched a hormonal intrauterine device (IUD) called Skyla. The product is launched in Europe with the brand name Jaydess, and is used for the prevention of pregnancy for up to three years.

Competitors/Players: Global Pulmonary/Respiratory Drug Delivery Market

• GlaxoSmithKline Pharma GmbH
• 3M,
• AstraZeneca,
• Boehringer Ingelheim
• Philips,
• PARI,
• GF Health Products Inc.,
• Merck
• Progressive Trade Media Limited
• BeyonDevices,
• Lda,
• Aphios Corporation,
• AptarGroup S. A.
• Novartis,
• Roche,
• TTP plc,
• Hovione,
• Teva Pharmaceutical,
• OMRON Group,
• Catalent Pharma Solutions.
• Sunovion Pharmaceuticals.,
• Cipla
• among others.

Know More Business Opportunities In Global Pulmonary And Respiratory Drug Delivery Market. Speak To Our Analyst And Gain Crucial Industry Insights That Will Help Your Business Expand Request Analyst Call at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-pulmonary-respiratory-drug-delivery-market

Competitive Analysis: Global Pulmonary/Respiratory Drug Delivery Market

The global pulmonary/respiratory drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pulmonary/respiratory drug delivery market for global, Europe, North America, Asia Pacific and South America.

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Pulmonary And Respiratory Drug Delivery Market Landscape
Part 04: Global Pulmonary And Respiratory Drug Delivery Market Sizing
Part 05: Five Forces Analysis
Part 06: Global Pulmonary And Respiratory Drug Delivery Market Segmentation By Product
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

And More…..Get Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-pulmonary-respiratory-drug-delivery-market

Market Segmentation: Global Pulmonary/Respiratory Drug Delivery Market

The Global Pulmonary/Respiratory Drug Delivery Market is segmented based on

• Canister Type,
• Application,
• End User,
• Formulation
• Geography

By formulation the global pulmonary/respiratory drug delivery market is segmented into type and device type. Type is further sub segmented into

• suspension aerosols,
• solution aerosols and
• dry powder formulations.
• Device type metered dose inhalers (MDIS),
• dry powder inhalers (DPIS)
• nebulizers

Nebulizers are further sub segmented into

• jet nebulizers,
• ultrasonic nebulizers
• soft mist nebulizers

By canister type the global pulmonary/respiratory drug delivery market is segmented into

• plain canisters
• coated canister.

On the basis of application the global pulmonary/respiratory drug delivery market is segmented into

• chronic obstructive pulmonary disease,
• asthma,
• cystic fibrosis
• others

On the basis of end user the global pulmonary/respiratory drug delivery market is segmented into

• hospitals & clinics
• home care settings.

Based on geography, the market report covers data points for 28 countries across multiple geographies namely

• North America & South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa.

Customization of the Report

• All segmentation provided above in this report is represented at country level. All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Major Market Drivers and Restraints:

• Growing preference for pulmonary drug delivery as an alternate route of drug delivery

• Development of smart/digital inhalers

• Increasing respiratory diseases

• Regulatory issues

• Pricing pressure

Primary Respondents

• Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Browser Full Report With Research Methodology at https://databridgemarketresearch.com/reports/global-pulmonary-respiratory-drug-delivery-market/

Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with us (sopan.gedam@databridgemarketresearch.com), we will ensure that you get a report that suits your needs.

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary And Respiratory Drug Delivery Market Comprehensive Study On AptarGroup S. A.,Novartis, Roche,TTP plc,Hovione,Teva Pharmaceutical, OMRON Group, Catalent Pharma Solutions., Sunovion Pharmaceuticals., Cipla, GlaxoSmithKline Pharma GmbH,3M here

News-ID: 1534756 • Views:

More Releases from Data Bridge Market Research

Wind Turbine Operations and Maintenance Market is estimated to grow at a Potential Growth Rate of 11.30% by 2028
Wind Turbine Operations and Maintenance Market is estimated to grow at a Potenti …
Industry Analysis The rise in investment in offshore wind turbines is escalating the growth of wind turbine operations and maintenance market. Wind turbine operations and maintenance refer to the services of maintaining the smooth working of the wind turbines. Wind energy means a renewable form of energy which is widely available on the surface of earth. The wind energy is generated by the conversion of wind flow into any useful form of
Warehouse Robotics Market Exceed Valuation of CAGR of 15.25% by 2029
Warehouse Robotics Market Exceed Valuation of CAGR of 15.25% by 2029
Industry Analysis Data Bridge Market Research report on warehouse robotics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the demand in the deployment of robotic systems is escalating the growth of warehouse robotics market. Warehouse robotics is referred to as the deployment of robotics in the warehouse to achieve functions including
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportunities, Top Companies, Regional Analysis and Forecast
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportuni …
The trustworthy Hibiscus Flower Powder Market study details the key actions taken by the leading companies and brands, including innovations, product launches, mergers, joint ventures, acquisitions, and competitive analysis in the industry. This winning market paper can cover more ground than just market scenarios and main players' pricing comparisons. It's a comprehensive background study of the sector that also estimates the parental market. A top-notch Hibiscus Flower Powder Market research report
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Strategies, Revenue, Challenges, Top Players and Forecast
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Stra …
A crucial source of information, the Caffeinated Beverage Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The

All 5 Releases


More Releases for Pulmonary

Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments